Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
2335.HKHKSEHealthcareBiotechnology
Latest quote
HK$28.14
−HK$1.22 · -4.16%
Aug 24, 11:57 AM HKT
2335.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteShaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It is designed for the treatment of SHPT, CKD-MBD with Osteoporosis and SHPT not on Dialysis. The company was founded by Wang Bing on January 19, 2007 and is headquartered in Xi'an, China.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Bing Wang
- Listed since
- Jun 24, 2026
- Employees
- 121
Market position
Day range
Current HK$28.14
HK$27.98HK$29.62
52-week range
Current HK$28.14
HK$27.00HK$45.04
- Open
- HK$29.34
- Previous close
- HK$29.36
- Volume
- 166.4K
- 0.19× average
- Average volume
- 861.98K
- Average daily volume
- Market cap
- 7.87B HKD
- Beta
- -0.13
- Market reference 1
- 50-day average
- HK$34.4952
- -18.42% below average
- 200-day average
- HK$34.4952
- -18.42% below average
2335.HK peers
Continue in GoAI
Research 2335.HKresearch.disclaimer